Clinical Trial Update: PTC299 and Hormonal Agent for Treatment of Metastatic Breast Cancer [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating PTC-299 in combination with a hormonal agent for metastatic breast cancer has completed, focusing on safety and preliminary …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Hormonal Agent
• PTC-299 (PTC-299)

Snippet

Sponsor: PTC Therapeutics | Conditions: Metastatic Breast Cancer | Phase 1 | Status: COMPLETED